Psychedelics in the Treatment of Psychiatric Disorders
Presented by Matthew Johnson, Ph.D.
6 Homestudy CE Credits

 Approved for Nevada Psychologists, LCSWs and MFTs.
 NPA is approved by the American Psychological Association to sponsor continuing education for psychologists.   NPA maintains responsibility for this program and its content.

 
Click Here to Register

About the Workshop

This pre-recorded CE training (presented in March of 2023) focuses on the treatment of psychiatric disorders with psychedelics. The presentation covers historical and modern research suggesting treatment efficacy for psychedelic compounds for disorders such as addiction, depression, and cancer-related distress.  Risks and methods for ensuring safety and maximizing efficacy are also explored. The presentation also discusses patient selection, preparation, monitoring (guiding) during psychedelic sessions, and follow-up discussion (integration), among other topics relevant to psychedelic therapy.

Learning Objectives

At the end of this pre-recorded program, participants will be able to:
1. Identify two risk factors that require mitigation in clinical research with high doses of psilocybin or other classic psychedelic compounds
2. Describe two "classic psychedelic" compounds 
3. Identify the current state of ethnic diversity in psychedelic therapy research
4. List two environmental factors that are involved in psychedelic therapy

About the Speaker

Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world’s most widely published experts on psychedelics. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received as principal investigator the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. He’s been Interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, CNN, NPR, Fox News,  Fox Business News, BBC and in Michael Pollan’s book How to Change Your Mind. Dr. Johnson's CV

Audience

This presentation is intended for psychologists, other licensed mental health providers, and graduate students of psychology.

General Information

Access to Webinar/Handout Materials:
This is a 6-hour pre-recorded presentation for homestudy CE credit. Electronic copy of handout materials will be sent out by email to attendee after registration is completed along with link(s) to view pre-recorded live, virtual webinar

Refunds & Grievance Policy: 
Participants may direct questions or grievances to NPA at (888) 654-0050. 

Approval and CE credit:
Nevada Psychological Association (NPA) is approved by the American Psychological Association to offer continuing education for psychologists. NPA maintains responsibility for the program and its content. 

If you want to receive homestudy CE credit for this pre-recorded presentation, you will need to complete and pass an online Post-Test Questions form.  According to APA’s Standards and Criteria for Approval of Sponsors, attendee must score at least 75% accuracy to qualify for CE credit, ensuring that attendee did actually attend and complete the program. Partial credit will not be issued to those that do not score at least 75% on posttest. Attendees are allowed three attempts to complete and pass the online posttest to receive CE credit.

Completion of the evaluation form is appreciated, forms are tabulated and reported to our CE Committee for discussion, analysis of participants’ satisfaction with content, instructor performance, etc.

CE certificate will be issued via email within 72 hours of receipt of post test and evaluation form, provided a passing score is obtained.

References

Johnson MW. Consciousness, religion, and gurus: Pitfalls of psychedelic medicine. ACS Pharmacology & Translational Science. 2020;4(2):578-81.

Johnson, Matthew W. "Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation." Disruptive Psychopharmacology (2022): 213-227.

Johnson MW. Psychiatry might need some psychedelic therapy. Introduction to issue: The renaissance in psychedelic research. Int Rev Psychiatry. 2018;30(4):285-90.

There is no potential conflict of interest and/or commercial support for this program or its presenter.